1,167
Views
1
CrossRef citations to date
0
Altmetric
Microbiology

Antimicrobial resistance in the times of COVID-19 in a roman teaching hospital

ORCID Icon, ORCID Icon, , , , , , ORCID Icon, ORCID Icon, & show all
Pages 452-457 | Received 14 Jun 2021, Accepted 09 Mar 2022, Published online: 31 Mar 2022

References

  • Blaize M, Mayaux J, Nabet C, Lampros A, Marcelin AG, Thellier M, Piarroux R, Demoule A, Fekkar A. 2020. Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient. Emerg Infect Dis. 26(7):1636–1637. doi:10.3201/eid2607.201603.
  • Cox MJ, Loman N, Bogaert D, O’Grady J. 2020. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 1(1):e11. doi:10.1016/S2666-5247(20)30009-4.
  • Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, et al. 2020. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in wuhan, china. Ann Am Thorac Soc. 17(7):839–84610.1513/AnnalsATS.202003-225OC.
  • Fontana C, Favaro M, Pistoia ES, Minelli S, Bossa MC, Altieri A, Testore GP, Leonardis F, Natoli S, Favalli C. 2007. The combined use of VIGI@ct® (bioMérieux) and fluorescent amplified length fragment polymorphisms in the investigation of potential outbreaks. J Hosp Infect. 66:262–268. doi:10.1016/j.jhin.2007.04.004.
  • Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. 2021. Tackling antimicrobial resistance in the COVID-19 pandemic. Available at the web site: https://www.who.int/bulletin/volumes/98/7/20-268573/en/. Accessed 2nd January 2021.
  • Hsu J. 2020. How COVID-19 is accelerating the threat of antimicrobial resistance. Br Med J. 369:m1983. doi:10.1136/bmj.m1983.
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. The Lancet. 395:497–506. doi:10.1016/S0140-6736(20)30183-5.
  • Kampmeier S, Tönnies H, Correa-Martinez CL, Mellmann  A, Schwierzeck V 2020. A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit. Antimicrob Resist Infect Control. 9(1):154. doi:10.1186/s13756-020-00820-8. PMID: 32962759.
  • Khailany RA, Safdar M, Ozaslan M. 2020. Genomic characterization of a novel SARS-CoV-2. Gene Reports. 19:100682. doi:10.1016/j.genrep.2020.100682.
  • Knight GM, Glover RE, McQuaid CF, Olaru ID, Gallandat K, Leclerc QJ, Fuller NM, Willcocks SJ, Hasan R, van Kleef E, Chandler CI. 2021. Antimicrobial resistance and COVID-19: intersections and implications. Elife. 10(10):e64139. doi:10.7554/eLife.64139.
  • Lansbury L, Lim B, Baskaran V, Lim WS. 2020. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Inf. 266. doi:10.1016/j.jinf.2020.05.046.
  • LeRose J, Sandhu A, Polistico J, Ellsworth J, Baran N, et al. 2020. The Impact of Combating COVID-19 on Blood Culture Contamination and Central Line Associated Bloodstream Infection Rates. Open Forum Infect Dis. 7:S316–S317. doi:10.1093/ofid/ofaa439.695.
  • Li Z, Chen ZM, Chen LD, Zhan YQ, Li SQ, Cheng J, Zhu AR, Chen LY, Zhong NS, Li SY, et al. 2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in patients with COVID-19 in guangzhou, china. J Med Virol. 92(11):2381–2383. doi:10.1002/jmv.26073. Epub 2020 Jul 27. PMID: 32462695; PMCID: PMC7283743.
  • Monnet  DL, Harbarth S. 2020. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Euro Surveill. 25(45):pii=2001886.
  • Monto AS, Fukuda K. 2019. Lessons from influenza pandemics of the last 100 years. Clin Infect Dis. 70(5):951–957. doi:10.1093/cid/ciz803.
  • No Authors. 2020. Antimicrobial resistance in the age of COVID-19. Nat Microbiol. 5:779. doi:10.1038/s41564-020-0739-4. Comment on Urban informal settlements as hotspots of antimicrobial resistance and the need to curb environmental transmission. Nadimpalli ML, Marks SJ, Montealegre MC, Gilman RH, Pajuelo MJ, Saito M, Tsukayama P, Njenga SM, Kiiru J, Swarthout J, Islam MA, Julian TR, Pickering AJ. Nat Microbiol. 2020 Jun;5(6):787-795. doi: 10.1038/s41564-020-0722-0. Epub 2020 May 25.
  • Nori P, Szymczak W, Puius Y, Sharma A, Cowman K, Gialanella P, et al. 2020. Emerging Co-pathogens: New Delhi metallo-beta-lactamase producing enterobacterales infections in New York city COVID-19 patients. Int J Antimicrob Agents. 56(6):106179. doi:10.1016/j.ijantimicag.2020.106179. PMID: 32987104.
  • Porretta AD, Baggiani A, Arzilli G, Casigliani V, Mariotti T, Mariottini F, et al. 2020. Increased risk of acquisition of New Delhi metallo-beta-lactamase-producing carbapenem-resistant enterobacterales (NDM-CRE) among a cohort of COVID-19 patients in a teaching hospital in tuscany, Italy. Pathogens. 9(8):635. doi:10.3390/pathogens9080635.
  • Reardon S. 2020. Treatment for covid-19 complications could fuel resistant bacteria. Science 2020. www.sciencemag.org/news/2020/04/antibiotic-treatment-covid-19-complications-could-fuel-resistant-bacteria10.1126/science.abc2995.
  • Rezasoltani S, Yadegar A, Hatami B, Asadzadeh Aghdaei H, Zali MR. 2020. Antimicrobial resistance as a hidden menace lurking behind the COVID-19 outbreak: The global impacts of too much hygiene on AMR. Front Microbiol. 11(11):590683. doi:10.3389/fmicb.2020.590683.
  • Ruan Q, Yang K, Wang W, Jiang L, Song J 2020. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from wuhan, China. Intensive Care Med. 46(5):846–848. doi:10.1007/s00134-020-05991-x.
  • Rusic D, Vilovic M, Bukic J, Leskur D, Seselja Perisin A, Kumric M, Martinovic D, Petric A, Modun D, Bozic J. 2021. Implications of COVID-19 pandemic on the emergence of antimicrobial resistance: Adjusting the response to future outbreaks. Life. 11:220. doi:10.3390/life11030220.
  • Sreepadmanabh M, Sahu AK, Chande A. 2020. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci. 45:148. doi:10.1007/s12038-020-00114-6.
  • Suh KN, Lee TB. 2021. Surveillance for Healthcare Infections Published by International Federation of Infection Control Wentworth Green Portadown, BT62 3WG, N Ireland, UK https://www.theific.org/wp-content/uploads/2017/02/Surv.pdf accessed on 3rd March 2021.
  • Tiri B, Sensi E, Marsiliani V, Cantarini M, Priante G, Vernelli C, Martella A, Costantini M, Mariottini A, et al. 2020. Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant klebsiella pneumoniae colonization in ICU COVID-19 patients. what did not work? J Clin Med. 9(9):2744. doi:10.3390/jcm9092744. PMID: 328543345.
  • Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z 2021. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 19:171–183. doi:10.1038/s41579-020-00461-z.
  • Venditti C, Butera O, Meledandri M, Balice MP, Cocciolillo GC, Fontana C, D’Arezzo S, De Giuli C, Antonini M, et al. 2021. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae. Clin Microbiol Infect. 27:1040.e1. doi:10.1016/j.cmi.2021.03.001.
  • Wang Z, Yang B, Li Q, Wen L, Zhang R. 2020. Clinical features of 69 cases With coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 71(15):769–777. doi:10.1093/cid/ciaa272.
  • Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, et al. 2020. Risk factors associated With acute respiratory distress syndrome and death in patients With coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 180(7):934–943. doi:10.1001/jamainternmed.2020.0994.